Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine release from peripheral cholinergic nerve endings refers to the biological process by which acetylcholine, a major neurotransmitter, is discharged from motor neurons and autonomic nerve fibers into synapses with muscles or glands. This release is tightly regulated by calcium influx, vesicle docking, and fusion proteins. The released acetylcholine binds to postsynaptic receptors, activating muscle contraction, glandular secretion, or modulating autonomic functions. Disruption or pharmacological manipulation of this process by toxins or drugs can lead to profound physiological effects, including paralysis, hyperactivity, or cardiovascular instability
Inhibition (e.g., botulinum toxin prevents vesicular release of ACh)\nExcessive stimulation (e.g., black widow spider venom causes massive ACh release resulting in overstimulation)\nModulation (various drugs affect upstream regulation, such as voltage-gated calcium channel blockers, but are not used therapeutically for this purpose in humans)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine release from peripheral cholinergic nerve endings.